BIBY REJI: Open Payments
NPI 1841079571 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 20 payments from 11 companies in 2025. Trend: 2023 $55 · 2024 $464 · 2025 $573
Food & beverage: $550Education: $23
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 3 | $99 |
| SOBI, INC | 3 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $87 |
| Astellas Pharma US Inc | 2 | $65 |
| Celgene Corporation | 2 | $65 |
| ABBVIE INC. | 2 | $60 |
| PharmaEssentia USA Corporation | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
Products named: Vonjo, Xospata, REBLOZYL, CALQUENCE, EPKINLY, BESREMI, VENCLEXTA, OJJAARA.
Industry payments across TX — which companies pay providers there.
